Navigation Links
Psychemedics Corporation Announces Second Quarter Results
Date:7/28/2008

$0.17 Dividend Declared

ACTON, Mass., July 28 /PRNewswire-FirstCall/ -- Psychemedics Corporation (Amex: PMD) today announced second quarter financial results for the period ended June 30, 2008. The Company also announced a quarterly dividend of $0.17 per share payable to shareholders of record as of September 5, 2008 to be paid on September 19, 2008. This will be the Company's 48th consecutive quarterly dividend.

The Company's second quarter revenue was $6.2 million, down 4% as compared to $6.5 million in the second quarter of 2007. Net income was $1.0 million or $0.20 per diluted share, down 23% from $1.3 million or $0.25 per share for the same period in 2007. The Company's revenue for the six months ended June 30, 2008 was $11.9 million, down 2% as compared to $12.2 million for the comparable period of 2007. Net income for the six months ended June 30, 2008 was $1.9 million or $0.36 per diluted share, a decrease of 19% over the comparable period last year during which the Company earned $2.4 million or $0.45 per share.

Raymond C. Kubacki, Chairman and Chief Executive Officer, said, "The jobs market remains a challenge, as the economy continues to see significant job losses through June -- in fact, six months of declines in a row. However, our revenues were off only slightly due to the fact that we continue to add new clients, thereby offsetting the weakness in hiring."

Kubacki continued, "We continue to make the investments in our sales and marketing in order to capitalize on significant future growth opportunities. This increased expense, as well as an increase in our legal expenses as compared to the same period last year, have caused our net income to be below our historic levels. Howe
'/>"/>

SOURCE Psychemedics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Psychemedics Corporation Announces First Quarter Results
2. Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue
3. Jennifer Chmieleski Joins Psychemedics Corporation as Top Financial Officer
4. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
5. HealthFitness Corporation to Report Second Quarter Financial Results
6. Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options
7. Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months
8. minSURG(TM) Corporation Launches International Division
9. Baxa Corporation Launches New Electronic Users Group Web Site
10. Leatt Corporation To Sponsor 2008 South African Motocross Grand Prix
11. China Medicine Corporation Obtains Australian Patent for rADTZ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... National Non-profit Launches Age-related Macu... at No Cost to Eligible Patients and Free Eye-Heal...isco, CA (Vocus) December 2, 2008 -- "Do You ...an eye disease known as Age-related Macular Degene..., , , , ,Picture this…. a large black hole...
(Date:12/2/2008)...wire-FirstCall/ -- Motorola, Inc. (NYSE: MOT ),...erbroadband system to enable,three hospitals mana...r,Generale de Sante to deliver voice, data and v...rovides an advanced IP broadband infrastructure to...xisting telephone line, eliminating,the need for ...
(Date:12/1/2008)... & Allergy Friendly, Toy Puppies to the Obama ...e-USNewswire/ -- Much has been made of President-E...But concerns about his daughter,s asthma and aller...ad from making a decision. So, in the meantime, t... is donating 2 "asthma & allergy friendly" toy...
(Date:12/1/2008)...s found that positron emission mammography (PEM), ...ected by either breast density or a woman,s hormon...s of standard mammography and MRI at detecting can... meeting of the Radiological Society of North Amer...er does not appear to be adversely affected by bre...
Breaking Medicine News(10 mins):Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 2Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 3Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 2Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 3Health News:Asthma and Allergy Foundation Helps New First-Dad Keep His First Promise 2Health News:New mammography technology effective in detecting breast cancer 2
...Biotechnologies, Inc., a wholly-owned subsidiary o... novel powder-based vaccine delivery technology m...uenza pandemic preparedness which were discussed b...ol of Influenza VI Conference" held in Toronto, Ca...
...r US vice president and presently a high profile e...rally, across the world Saturday next. He is behin... pop and rock music featuring various artists plan...7, 2007 to promote action to confront the global w...
...ithstanding, violent hate crimes on the rise again... Nearly four in 10 gay men and about one in eight ...een the target of violence or a property crime bec...ientation, according to a new study. "This is the...
...the abattoir, especially because it is afflicted w...m the mad cow disease that took a heavy toll of t...-year-old Freisian bull to the slaughterhouse is b...t" Hindus of Carmarthenshire, a tiny hamlet in Wal...
Other Medicine News:Health News:DelSite Working Toward Solving Delivery of Influenza Vaccine in Pandemic Situations 2Health News:DelSite Working Toward Solving Delivery of Influenza Vaccine in Pandemic Situations 3Health News:Live Earth Will Make the World More Aware of the Crisis Facing the Earth, Hopes Al Gore 2Health News:Live Earth Will Make the World More Aware of the Crisis Facing the Earth, Hopes Al Gore 3Health News:Hate Crimes Against Gays and Lesbians Rising in US 2Health News:Shambu With Bovine TB Being Prevented from Slaughter 2
(Date:12/1/2008)...n has announced that an oral,presentation of pre...nical,trial of TG101348 in myeloproliferative dis...ican Society of Hematology (ASH) Meeting. , , ... Title: A Phase I Study of TG10134... JAK2-Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)... , , ROCHESTER, Minn., Dec. 1 /PRNewswire-...the use of the drug therapy etanercept ineffective...ation of the liver caused by excessive consumption...d in the December issue of Gastroenterology ( ht...LERT: Additional audio and video resources, includ...
(Date:12/1/2008)...-- Vical Incorporated (Nasdaq: VICL ) announced ...ent from Merck & Co., Inc. based on Merck,s pl... investigational plasmid DNA (pDNA) cancer vaccine...ne delivery technology and encodes human telomeras...ect of separate license agreement. , , "The...
(Date:11/27/2008)...phoblastic leukemia relapse cases arise from a cel..., MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNewswire...spital have identified distinctive genetic changes...blastic leukemia (ALL) that cause relapse. The fin...ALL relapse in children and, ultimately, in adults...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3American Society for Microbiology honors Vickie S Baselski 4075 1American Society for Microbiology honors Vickie S Baselski 4075 2American Society for Microbiology honors Vickie S Baselski 4075 3American Society for Microbiology honors Vickie S Baselski 4075 4The TPAA Names Mark Oelschlager President 6584 1The TPAA Names Mark Oelschlager President 6584 2Booster vaccination may help with possible future avian influenza pandemic 24115 1Booster vaccination may help with possible future avian influenza pandemic 24115 2Booster vaccination may help with possible future avian influenza pandemic 24115 3VSP Vision Care Takes Tax Exempt Appeal to Supreme Court 24112 1VSP Vision Care Takes Tax Exempt Appeal to Supreme Court 24112 2VSP Vision Care Takes Tax Exempt Appeal to Supreme Court 24112 3
...igestive Disease Week -, CAMBRIDGE, Mass., May 21,... presentation of data from a Phase 2 study in whic...oved bowel function,in patients with constipation-...se data also showed linaclotide was well tolerated...de is a first-in-class,compound currently being de...
...ay 21, 2007 - Medical,professionals seeking to tre...uired gram-negative pneumonia may have a new weapo... candidate being,developed by Nektar Therapeutics ...al evaluating the use of,NKTR-061 (Inhaled Amikaci...hospital-acquired gram-negative pneumonia were,pre...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11
The Anterior Isola System is intended for use in correcting scoliotic, lordotic or kyphotic spinal deformities by establishing an axially stiff fixation bridge parallel to the long axis of the spine.
...Bowman Perfusion Monitor measures focal tissue per.... This precision instrument activates the minimall... connected by an umbilical cord to collect the dat... a host PC via serial port for processing, storage...
The Laserflo BPM2 is designed to give accurate and continuous cerebral blood flow data in neurosurgical intensive care, trauma, and operating room settings. The system is safe and easy to use, and pr
Oxyflo is a highly featured laser doppler system for continuous monitoring of microvascular blood perfusion from multiple tissue sites. This latest generation system incorporates developments in Digi
Medicine Products: